Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2013
Modified cisplatin, etoposide, and ifosfamide (PEI) salvage therapy for male germ cell tumors: long-term efficacy and safety outcomesA Necchi, N Nicolai, L Mariani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: post-progression outcomes from the phase II IMvigor210 studyA Necchi, R W Joseph, Y Loriot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2017
Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trialA Necchi, S Lo Vullo, P Giannatempo, et al.
ESMO Open|December 3, 2022
Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterationsK Murugesan, A Necchi, T C Burn, et al.
ESMO Open|November 19, 2025
Outcomes of immune checkpoint inhibitor rechallenge in advanced urothelial carcinoma: results from a global real-world evidence studyB A Maiorano, A Cigliola, V Tateo, et al.
Investigational New Drugs|February 26, 2014
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trialA Necchi, P Giannatempo, L Mariani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2023
Pemigatinib for metastatic or surgically unresectable urothelial carcinoma with FGF/FGFR genomic alterations: final results from FIGHT-201A Necchi, D Pouessel, R Leibowitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2020
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study<sup>☆</sup>M Bandini, E A Gibb, A Gallina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2015
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)M De Santis, P J Wiechno, J Bellmunt, et al.
ESMO Open|April 22, 2026
Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence studyA Cigliola, B A Maiorano, F Rossari, et al.
Pageof 4